|
Medtronic received a report that the axium prime coil prematurely detached.The patient was undergoing treatment for an unruptured, saccular aneurysm located in the anterior communicating artery.The max diameter was 3mm, and the neck diameter was 2.7mm.The patient's blood flow and vessel tortuosity were normal.It was reported that the coil was accidentally detached during use, but was implanted in the intended location.No additional medical or surgical intervention was needed.The coil pushwire was not bent or broken.There was no friction or difficulty during delivery, and the physician had not repositioned the coil.No detachment attempts had been made.The physician did not rotate the delivery pushwire during the procedure, and a continuous flush had been administered. the patient did not experience any injury or complications.The devices were prepared according to the instructions for use (ifu).
|
|
H3: analysis of the axium coil (lot no.A977234) found the pusher actuator interface (ai) and hypotube break indicator (hbi) were intact.The axium prime pusher was found bent at ~34.4 cm from the pusher distal end.The axium prime pusher release wire coin was found against the lumen stop, the shield coil was found intact, and the implant coil was not still attached to the pusher.The implant coil was not returned.The release wire tip was found extending out of the distal end of the pusher for 0.002¿ which is within specification (specification:.002-.005¿).The release wire was pulled out of the pusher for evaluation of the coin.The release wire coin was found to be visually acceptable.The coin width was measured at 3 locations and was found to be within specifications.The coin width was measured at 0.063 mm to be 0.087 mm, at 0.127 mm to be 0.099 mm, and at 0.275 mm to be 0.098 mm (specification: at 0.063 mm: 0.063 mm-0.089 mm; at 0.127 mm: 0.075 mm-0.105 mm; at 0.275 mm: 0.086 mm-0.108 mm).The inner diameter of the retainer ring was found to be visually acceptable.The retainer ring inner diameter (id) was measured to be 0.0042¿ which is not within specification (specification: 0.00455" ±.00010).Based on the device analysis and reported information, the customer¿s report of ¿premature detachment¿ was confirmed; however, the root cause could not be determined.Premature detachment can occur due to tortuous anatomy, implant coil is not retracted in a one-to-one motion with the pusher during repositioning, pusher rotation, user advances the device against resistance, pusher damage, damage to retainer ring, retainer ring id above specification, or implant coil detachment ball outer diameter (od) below specification.The patient¿s vessel tortuosity was ¿normal¿, there was no friction or difficulty during delivery of the device, the device was not repositioned, and the pusher was not rotated during delivery.The implant coil was not returned; therefore, analysis could not be performed and conformance to specification could not be assessed.It is possible the damage found with the returned pusher contributed to the event; however, the cause for the damage could not be determined.The retainer ring was found to be in good condition; however, the id was measured below specification.As the retainer ring id was not found above specification the dimension issue is unlikely to contribute to the event.H6: method code updated to b01.Result code updated to c070601, c070603.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|